Caprylex
Caprylex, licence 80076718: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80076718
- Status
- Active licence
- Licence date
- 13 April 2017
- Revision date
- 11 May 2017
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Phosphate de calcium, dibasique, dihydraté | 87.0 milligramme | 174,000 µg |
| Phosphore Source : Phosphate de calcium, dibasique, dihydraté | 68.0 milligramme | 136,000 µg |
| Acide octanoïque Source : Caprylate de sodium | 300.0 milligramme | Not calculated |
| Magnésium Source : Oxyde de magnésium | 50.0 milligramme | 100,000 µg |
Non-medicinal ingredients
Acide stéarique, Poly(éthylène glycol), Poudre de girofle, Poly(sorbate) 80, Cellulose, Poudre de racine de Raifort, Talc, Éthylcellulose, Stéarate de magnésium, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Helps in energy metabolism, tissue formation and bone development. Helps in the development and maintenance of bones and teeth. Helps in the process of normal regulation of cell division and specialisation. Helps to maintain normal electrolyte balance. Helps to maintain normal muscle function. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain proper muscle function. Helps to maintain the body's ability to metabolize nutrients. Source of/An electrolyte for the maintenance of good health. Source of minerals, a factor/factors in the maintenance of good health. Source of minerals to support biological functions which play a key role in the maintenance of good health. Multi-mineral supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80076718
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.